… patients, pregnant women and patients with underlying co-morbidities. There is no approved
treatment for COVID-19; … to each patient's need (eg antipyretics for fever, oxygen therapy for …

… therapy (in primis … , therapy) are guided by the clinical context and the COVID-19 severity.
We provide a practical approach on antithrombotic therapy management for COVID-19 patients …

… outpatient antithrombotic therapy trials for COVID-19 are large, … patients We identified 50
ongoing RCTs related to antithrombotic therapy in hospitalized non-ICU patients with COVID-19…

… In our recommendations, we focused on physical therapists managing hospitalized patients
with COVID-19. However, it is important that recommendations will be provided for the …

… In the treatment of patients suffering from corona virus disease, the use … Patients suffering
from coronavirus disease are treated in our center. In addition to the treatment of these patients, …

… can be used as therapy for patients with COVID-19 without severe adverse events. One
possible explanation for the efficacy of convalescent plasma therapy is that the antibodies …

… In this study, 1,120 patients received nirmatrelvir plus ritonavir therapy and 1,126 … drugs
for patients with mild and common COVID-19. This work also suggests that FNC is effective for …

… Additionally, a growing body of data suggests that some patients with COVID-19, including
individuals with mild symptoms, will have a variably prolonged course of recovery including …

… Whether the magnitude of benefit of anti-inflammatory therapies in patients with COVID-19
differs according to the level of kidney function at baseline has not been assessed. …

… COVID-19 vaccine response in these patients. With this in mind, this article outlines the
existing data on the effect of antirheumatic therapy on vaccine responses in patients … COVID-19 …